Prostatype Genomics AB (publ) at its annual general meeting held on 23 May 2024, Johan Waldhe was elected as new member of the board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 SEK | +13.04% | -40.91% | -72.63% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-72.63% | 2.18M | |
-16.40% | 8.42B | |
+67.76% | 4.31B | |
+3.94% | 2.72B | |
-2.80% | 2.62B | |
-53.41% | 1.9B | |
-19.59% | 1.66B | |
-21.62% | 1.42B | |
+16.16% | 1.2B | |
-46.45% | 1.11B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics AB Elects Johan Waldhe as New Member of the Board